Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
SMI 10'268 1.4%  SPI 13'166 1.5%  Dow 28'726 -1.7%  DAX 12'114 1.2%  Euro 0.9672 1.0%  EStoxx50 3'318 1.2%  Gold 1'661 0.0%  Bitcoin 19'178 0.6%  Dollar 0.9886 0.1%  Öl 87.9 -1.1% 
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
15.08.2022 14:14:38

Novavax submits FDA application for its COVID-19 booster

Novavax Inc. said Monday that it asked the Food and Drug Administration to authorize its COVID-19 booster for adults. The company's primary series of protein-based shots received FDA authorization in July. "We believe our vaccine offers a broad, long-lasting immune response against a range of variants," Novavax CEO Stanley Erck said in a news release. Novavax said giving a third shot of its vaccine to adults six months after getting the first two Novavax shots boosted antibody levels that were comparable to or exceeded levels reported after the first two shots. Novavax's stock has declined 71.0% this year, while the broader S&P 500 is down 10.2%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Weiter zum vollständigen Artikel bei "Market Watch"

INFLATION: WELTWEIT STEIGEN DIE PREISE

Viele Anleger setzen deshalb auf den Aktiv verwalteten Global Inflation Protection Basket. Informieren Sie sich über die breit gestreute Auswahl an robusten Aktien & ETFs.